Skip to main content
. 2021 Feb 27;3(1):dlab003. doi: 10.1093/jacamr/dlab003

Figure 2.

Figure 2.

Point prevalence estimates of resistance to nitrofurantoin in E. coli and K. pneumoniae by country in the Asia-Pacific region, stratified by surveillance strategy (laboratory-based surveillance, population-based surveillance). The horizontal line indicates the 95% CI. An asterisk (*) indicates the study only included ESBL-producing isolates.